Broken redirects

Jump to navigation Jump to search

The following redirects link to non-existent pages:

Showing below up to 50 results in range #2,251 to #2,300.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. How to insert image → Help:Images
  2. Linking → Help:Links
  3. NOTOC → Help:Section
  4. Help → Help:Who what where why how
  5. Alkyl and aryl transferases → Category:EC 2.5
  6. Nitrogenous group transferases → Category:EC 2.6
  7. Carbon-carbon double bond isomerases → Category:EC 5.3.3
  8. Sulfur-sulfur bond isomerases → Category:EC 5.3.4
  9. Phosphotransferases (phosphomutases) → Category:EC 5.4.2
  10. Amide synthases → Category:EC 6.3.1
  11. Carbon-nitrogen ligases with glutamine as amide-n-donor → Category:EC 6.3.5
  12. AMI:Fixing the GAP-Quality Improvement Program for AMI Shown to be Effective → Special:Badtitle/NS100:AMI:Fixing the GAP-Quality Improvement Program for AMI Shown to be Effective
  13. A large study demonstrates no gender differences in short- and long-term outcomes following PCI → Special:Badtitle/NS100:A large study demonstrates no gender differences in short- and long-term outcomes following PCI
  14. A meta-analysis of over 180,000 patients suggests that drug eluting stents are safe for both on-label and off-label use → Special:Badtitle/NS100:A meta-analysis of over 180,000 patients suggests that drug eluting stents are safe for both on-label and off-label use
  15. Abciximab in addition to a high loading dose of clopidogrel does not improve outcomes in STEMI patients: Results from the BRAVE-3 Trial → Special:Badtitle/NS100:Abciximab in addition to a high loading dose of clopidogrel does not improve outcomes in STEMI patients: Results from the BRAVE-3 Trial
  16. Abnormal pressure gradient distal to the implanted bare metal stent is associated with the occurrence of in-stent restenosis → Special:Badtitle/NS100:Abnormal pressure gradient distal to the implanted bare metal stent is associated with the occurrence of in-stent restenosis
  17. Absorbable drug eluting stents are safe up to one year in single de novo coronary artery lesions → Special:Badtitle/NS100:Absorbable drug eluting stents are safe up to one year in single de novo coronary artery lesions
  18. Acoustic Cardiography: New Technique for Resynchronization Device Optimization May Provide Improved Outcomes → Special:Badtitle/NS100:Acoustic Cardiography: New Technique for Resynchronization Device Optimization May Provide Improved Outcomes
  19. Acute Myocardial Infarction with Hyperoxemic Therapy II (AMIHOT II) in ST Elevation MI with Rebuttal by Dr. Stone → Special:Badtitle/NS100:Acute Myocardial Infarction with Hyperoxemic Therapy II (AMIHOT II) in ST Elevation MI with Rebuttal by Dr. Stone
  20. Acute ischemic stroke: a decade of education and clinical investigation isn’t enough → Special:Badtitle/NS100:Acute ischemic stroke: a decade of education and clinical investigation isn’t enough
  21. Adjusting Clopidogrel loading dose according to platelet reactivity monitoring is associated with a decreased rate of stent thrombosis and no increase in bleeding → Special:Badtitle/NS100:Adjusting Clopidogrel loading dose according to platelet reactivity monitoring is associated with a decreased rate of stent thrombosis and no increase in bleeding
  22. Almost two years after implantation, Sirilimus-eluting coronary stents remain exposed to the circulation. August 11, 2007 → Special:Badtitle/NS100:Almost two years after implantation, Sirilimus-eluting coronary stents remain exposed to the circulation
  23. Angiomax Monotherapy Associated with Reduced Net Adverse Clinical Events, Major Bleeding and Cardiac‐Related Death Compared to Heparin Plus a Glycoprotein IIb/IIIa Inhibition in Primary PCI: Results of HORIZONS AMI → Special:Badtitle/NS100:Angiomax Monotherapy Associated with Reduced Net Adverse Clinical Events, Major Bleeding and Cardiac‐Related Death Compared to Heparin Plus a Glycoprotein IIb/IIIa Inhibition in Primary PCI: Results of HORIZONS AMI
  24. Antioxidants: WACS Study Demonstrates No Significant Benefit From Antioxidants For Preventing CVD → Special:Badtitle/NS100:Antioxidants: WACS Study Demonstrates No Significant Benefit From Antioxidants For Preventing CVD
  25. Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty 5 (ARMYDA-5) Presented Today at TCT 2007 → Special:Badtitle/NS100:Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty 5 (ARMYDA-5) Presented Today at TCT 2007
  26. Antiplatelets: Clopidogrel-to-Ticlopidine Crossover Study Demonstrates Drug Specific Resistance → Special:Badtitle/NS100:Antiplatelets: Clopidogrel-to-Ticlopidine Crossover Study Demonstrates Drug Specific Resistance
  27. Anxious individuals are at risk for heart attacks → Special:Badtitle/NS100:Anxious individuals are at risk for heart attacks
  28. Apixaban causes increased bleeding, but reduced ischemic events in patients with recent acute coronary syndrome: Results of the APPRAISE-1 Trial → Special:Badtitle/NS100:Apixaban causes increased bleeding, but reduced ischemic events in patients with recent acute coronary syndrome: Results of the APPRAISE-1 Trial
  29. Arginine metabolite found to predict mortality in patients with cardiogenic shock → Special:Badtitle/NS100:Arginine metabolite found to predict mortality in patients with cardiogenic shock
  30. Aspiration before Primary PCI Improves Outcomes: Results of EXPIRA and EXPORT → Special:Badtitle/NS100:Aspiration before Primary PCI Improves Outcomes: Results of EXPIRA and EXPORT
  31. Atherosclerosis: Study links atherosclerosis progression to traffic exposure → Special:Badtitle/NS100:Atherosclerosis: Study links atherosclerosis progression to traffic exposure
  32. Atrial tachyarrhythmia burden ≥5.5h in a day doubles the risk for thromboembolism in the TRENDS study → Special:Badtitle/NS100:Atrial tachyarrhythmia burden ≥5.5h in a day doubles the risk for thromboembolism in the TRENDS study
  33. Automated External Defibrillators offer no benefit in cardiac arrests that occur at home in the HAT trial → Special:Badtitle/NS100:Automated External Defibrillators offer no benefit in cardiac arrests that occur at home in the HAT trial
  34. BEAUTIFUL study fails to meet primary endpoint but demonstrates that heart rates can safely be reduced with Ivabradine → Special:Badtitle/NS100:BEAUTIFUL study fails to meet primary endpoint but demonstrates that heart rates can safely be reduced with Ivabradine
  35. Better to be a pear than an apple: new prospective look at associations between fat distribution and coronary heart disease → Special:Badtitle/NS100:Better to be a pear than an apple: new prospective look at associations between fat distribution and coronary heart disease
  36. Biolimus Eluting Stents Shown to be as Safe and Effective as Sirolimus Eluting Stents in Everyday Clinical Practice: Results from the LEADERS Trial → Special:Badtitle/NS100:Biolimus Eluting Stents Shown to be as Safe and Effective as Sirolimus Eluting Stents in Everyday Clinical Practice: Results from the LEADERS Trial
  37. Bivalirudin during primary PCI reduces major bleeding and adverse events at 30 days in the HORIZONS-AMI trial → Special:Badtitle/NS100:Bivalirudin during primary PCI reduces major bleeding and adverse events at 30 days in the HORIZONS-AMI trial
  38. Bivalirudin is no better than heparin in patients pretreated with clopidogrel undergoing PCI: Results from the ISAR-REACT-3 trial → Special:Badtitle/NS100:Bivalirudin is no better than heparin in patients pretreated with clopidogrel undergoing PCI: Results from the ISAR-REACT-3 trial
  39. Cardiac Resynchronization Therapy and Single Center Experience Links Survival → Special:Badtitle/NS100:Cardiac Resynchronization Therapy and Single Center Experience Links Survival
  40. Cardiac arrest during weekends and nights is associated with poor outcomes → Special:Badtitle/NS100:Cardiac arrest during weekends and nights is associated with poor outcomes
  41. Cardiogenic Shock: New Treatment Options with Percutaneous Left Ventricular Assist Devices? → Special:Badtitle/NS100:Cardiogenic Shock: New Treatment Options with Percutaneous Left Ventricular Assist Devices?
  42. Cardiologists’ Use of Pulmonary Artery Catheter Information in CCU Treatment Decisions → Special:Badtitle/NS100:Cardiologists’ Use of Pulmonary Artery Catheter Information in CCU Treatment Decisions
  43. Cardiovascular risk increases with incremental doses of celecoxib → Special:Badtitle/NS100:Cardiovascular risk increases with incremental doses of celecoxib
  44. Changes in Residents’ Hours of Work Not Generally Reflected in Improved Outcomes → Special:Badtitle/NS100:Changes in Residents’ Hours of Work Not Generally Reflected in Improved Outcomes
  45. Clinical Research Organizations (CROs), Academic Research Organizations (AROs), or Industry: Who’s best for clinical research → Special:Badtitle/NS100:Clinical Research Organizations (CROs), Academic Research Organizations (AROs), or Industry: Who’s best for clinical research
  46. Clinical data support the non-inferiority of continuous chest compressions compared with conventional cardiopulmonary resuscitation → Special:Badtitle/NS100:Clinical data support the non-inferiority of continuous chest compressions compared with conventional cardiopulmonary resuscitation
  47. Clot retrieval from the coronary arteries during primary angioplasty improves myocardial perfusion and clinical outcomes → Special:Badtitle/NS100:Clot retrieval from the coronary arteries during primary angioplasty improves myocardial perfusion and clinical outcomes
  48. CoStar Drug Eluting Stent is not Non-inferior to TAXUS Drug Eluting Stents → Special:Badtitle/NS100:CoStar Drug Eluting Stent is not Non-inferior to TAXUS Drug Eluting Stents
  49. Cocoa Containing Flavanols might be Beneficial in Diabetic Patients with Vascular Dysfunction → Special:Badtitle/NS100:Cocoa Containing Flavanols might be Beneficial in Diabetic Patients with Vascular Dysfunction
  50. Coronary Calcium Coverage Score is Associated with an Increase in the Risk of Coronary Artery Disease → Special:Badtitle/NS100:Coronary Calcium Coverage Score is Associated with an Increase in the Risk of Coronary Artery Disease

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://www.wikidoc.org/index.php/Special:BrokenRedirects"